ribavirin has been researched along with Basedow Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Chang, YS; Chen, JH; Chen, SC; Chou, SM; Hsu, HC; Kuo, TT; Lin, TM; Shen, YC; Yeh, HJ | 1 |
| Duncea, I; Pepene, CE | 1 |
| Hayashi, M; Kataoka, Y; Koguchi, H; Tachikawa, K; Tanaka, H | 1 |
| Archimandritis, AJ; Giannaris, M; Koskinas, J; Malaktari, S; Papakostas, N; Savvas, SP | 1 |
| Fujioka, T; Honda, M; Koyama, K; Matsuno, H; Ogawa, M; Shimokawa, K; Yoshizaki, T | 1 |
| Halota, W; Kozielewicz, D | 1 |
| Chang, TC; Chang, YC; Liao, SL; Su, DH | 1 |
| Alam-Fotias, S; Bui, C; Mansberg, R; Nguyen, D; Shen, L | 1 |
8 other study(ies) available for ribavirin and Basedow Disease
| Article | Year |
|---|---|
Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Topics: Cohort Studies; Graves Disease; Hashimoto Disease; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Retrospective Studies; Ribavirin; Risk Factors | 2022 |
IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report.
Topics: Antiviral Agents; Drug Therapy, Combination; Graves Disease; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Recurrence; Ribavirin; Thyroidectomy; Thyrotoxicosis; Thyrotropin; Thyroxine | 2008 |
Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Graves Disease; Hepatitis C, Chronic; Histocompatibility Antigens Class I; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.
Topics: Adult; Antiviral Agents; Autoantibodies; Autoantigens; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Graves Disease; Hashimoto Disease; Hepatitis C, Chronic; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Iodide Peroxidase; Iron-Binding Proteins; Male; Polyethylene Glycols; Receptors, Thyrotropin; Recombinant Proteins; Ribavirin; Th1 Cells; Th2 Cells | 2010 |
A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-α plus ribavirin treatment for chronic hepatitis C.
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyendocrinopathies, Autoimmune; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Secondary Prevention; Treatment Outcome | 2010 |
Interferon-induced thyroiditis during treatment of chronic hepatitis C.
Topics: Age Factors; Algorithms; Antithyroid Agents; Antiviral Agents; Autoantibodies; Diagnosis, Differential; Drug Interactions; Female; Graves Disease; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin; Risk Factors; Sex Factors; Thyroid Gland; Thyroiditis | 2012 |
Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Peptides, Cyclic; Ribavirin; Somatostatin; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
Topics: Adult; Antiviral Agents; Female; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Radionuclide Imaging; Radiopharmaceuticals; Ribavirin; Sodium Pertechnetate Tc 99m; Thyroiditis | 2005 |